CCCC
C4 Therapeutics, Inc.
stockNASDAQ
Market OpenNov 12, 2026 9:44:48 AM EST
2.77USD-4.152%(-0.12)92,485
Pre-marketNov 12, 2026 9:21:30 AM EST
2.85USD-1.384%(-0.04)
CCCC Financials
In Q3 FY 2026 (ended ), C4 Therapeutics, Inc. (CCCC) reported revenue of $8.47M, net income of −$21.84M, operating cash flow of −$25.97M, and assets of $331.8M (filed ).
Loading financial statements…